Filing Details
- Accession Number:
- 0001144204-16-120408
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-08-19 17:59:31
- Reporting Period:
- 2016-08-04
- Filing Date:
- 2016-08-19
- Accepted Time:
- 2016-08-19 17:59:31
- Original Submission Date:
- 2016-08-04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1208261 | Immune Pharmaceuticals Inc | IMNP | Pharmaceutical Preparations (2834) | 521841431 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1584822 | Gedeon Daniel Teper | C/O Immune Pharmaceuticals Inc. 430 East 29Th Street, Suite 940 New York NY 10016 | Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-04 | 868,902 | $0.41 | 5,679,807 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On August 4, 2016, the Reporting Person filed a Form 4 with the Commission (the "Original Form 4"). The Original Form 4 included the issuance of 937,500 restricted shares of the Issuer's common stock to be issued to the Reporting Person upon repayment of a $356,250 promissory note. The Original Form 4 erroneously indicated that (i) the conversion price of the promissory note was $0.38 per share and (ii) the Reporting Person received 937,500 restricted shares of the Issuer's common stock. The Reporting Person received 868,902 restricted shares of the Issuer's common stock at a conversion price of $0.41 per share.
Billionaire Hedge Funds
